EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MicroRNA Biogenesis Pathway Gene Variants Are Associated with Prostate Cancer Susceptibility

Irina Gilyazova iD, Yanina Timasheva, Elizaveta Ivanova, Galiya Gimalova iD, Adel Izmailov, Gulshat Abdeeva, Murat Dzaubermezov iD, Zhanna Balkhiyarova iD, Inga Prokopenko iD, Valentin Pavlov iD, Elza Khusnutdinova

International Journal of Molecular Sciences · 20.06.2026 · 27 (12) · 5578

DOI: 10.3390/ijms27125578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.06.2026. Verfasst von Irina Gilyazova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, 450054 Ufa, Russia. Hauptthemen laut MEDLINE: MicroRNAs, Prostatic Neoplasms, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Education and Science of the Russian Federation, the state assignment of the Ministry of Science and Higher Education of the Russian Federation, Collection of Biological Materials of Human Beings of the IBG UFRC RAS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PrC) is one of the most common malignancies among men worldwide. However, the contribution of genetic variation in microRNA (miRNA) biogenesis pathway genes to PrC susceptibility remains poorly characterized in many ethnically diverse populations. We conducted a case–control study involving 532 PrC patients and 550 controls from the Volga-Ural region of Eurasia to evaluate the association of twenty-one single nucleotide polymorphisms (SNPs) with PrC risk using single-variant and polygenic approaches. Association analyses identified rs595055 in the AGO1 gene as significantly associated with PrC risk after correction for multiple testing. To evaluate the cumulative effect of genetic variation, weighted and unweighted polygenic risk scores (PRSs) were constructed. The weighted PRS was significantly associated with PrC risk (odds ratio per standard deviation increase = 1.63, 95% CI [1.43–1.85], P = 1.37 × 10−13), and demonstrated moderate discriminatory performance (AUC = 63.1%), outperforming the unweighted model. Individuals in the highest PRS quartile had approximately threefold higher odds of PrC than those in the lowest quartile. Combining the weighted PRS with prostate-specific antigen improved discrimination (AUC = 68.1%). These findings support the contribution of miRNA biogenesis pathway genes to PrC susceptibility and highlight the potential value of pathway-based polygenic risk stratification in understudied populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsProstatic NeoplasmsGenetic Predisposition to DiseasePolymorphism, Single NucleotideArgonaute ProteinsEukaryotic Initiation FactorsHumansMaleGenetic Risk ScoreCase-Control StudiesMiddle AgedAged

Stichwörter der Autor:innen

genetic risk scoremiRNAprostate cancer

Substanzen

MicroRNAsAGO1 protein, humanArgonaute ProteinsEukaryotic Initiation Factors

Autor:innen und Institutionen

  • Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, 450054 Ufa, Russia.
  • Institute of Urology and Clinical Oncology, Department of Medical Genetics and Fundamental Medicine, Bashkir State Medical University, 450008 Ufa, Russia.
  • Laboratory of Population and Medical Genetics, Ufa University of Science and Technology, 450076 Ufa, Russia.
  • Department of Clinical & Experimental Medicine, University of Surrey, Guildford GU2 7XH, UK.

ORCID-Profile: Irina Gilyazova, Galiya Gimalova, Murat Dzaubermezov, Zhanna Balkhiyarova, Inga Prokopenko, Valentin Pavlov

Förderung

  • The Ministry of Education and Science of the Russian Federation
  • the state assignment of the Ministry of Science and Higher Education of the Russian Federation
  • Collection of Biological Materials of Human Beings of the IBG UFRC RAS

Zitieren

APA

Gilyazova, I., Timasheva, Y., Ivanova, E., Gimalova, G., Izmailov, A., Abdeeva, G., Dzaubermezov, M., Balkhiyarova, Z., Prokopenko, I., Pavlov, V., & Khusnutdinova, E. (2026). MicroRNA Biogenesis Pathway Gene Variants Are Associated with Prostate Cancer Susceptibility. International Journal of Molecular Sciences, 27(12), 5578. https://doi.org/10.3390/ijms27125578

Vancouver

Gilyazova I, Timasheva Y, Ivanova E, Gimalova G, Izmailov A, Abdeeva G, et al. MicroRNA Biogenesis Pathway Gene Variants Are Associated with Prostate Cancer Susceptibility. International Journal of Molecular Sciences. 2026;27(12):5578. doi:10.3390/ijms27125578

BibTeX
@article{Gilyazova2026,
  author = {Gilyazova, Irina and Timasheva, Yanina and Ivanova, Elizaveta and Gimalova, Galiya and Izmailov, Adel and Abdeeva, Gulshat and Dzaubermezov, Murat and Balkhiyarova, Zhanna and Prokopenko, Inga and Pavlov, Valentin and Khusnutdinova, Elza},
  title = {MicroRNA Biogenesis Pathway Gene Variants Are Associated with Prostate Cancer Susceptibility},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {12},
  pages = {5578},
  doi = {10.3390/ijms27125578}
}
Kostenlos starten →